COVID-19 & Research Restart

OVCR Research-Related Updates Regarding COVID-19 Emergency and Research Restart

FAQs: Physician Payments Sunshine Act

Printable Version of FAQs

The Physician Payment Sunshine Act was designed with the objective of creating transparency of financial interests of physicians.  However, it also has the potential to diminish public trust in academic and research institutions.  This can occur when there are inconsistencies between information reported to the federal government versus the information disclosed to the University.

The Physician Payment Sunshine Act, under the Affordable Healthcare Act (Public Law 111-148, Section 6002), places obligations for public disclosure of payments and financial interests made to physicians by manufacturers of drugs, devices, biologicals, and medical supplies as well as group purchasing organizations (GPOs).  The information has been collected by and was made publicly available by the Centers for Medicare and Medicaid Services (CMS).  The database will be updated by the end of 2014.  Thereafter, CMS will update the database annually on June 30.

As a physician, there is information about the Act with which you should be aware.   You are strongly encouraged to cooperate with CMS, manufacturers, and GPOs to ensure accurate reporting of your financial interests and payments made to you that are publically disclosed on the CMS website.

The University requires that your disclosure of non-University activities be consistent with the information reported in the CMS database.  Below is information on what you must do to be in compliance with the University’s Policy on Conflict of Commitment and Interest.